Venture Capital

Sonder Capital

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Private Equity, Venture Capital

Stage Focus
Seed, Series A, Series B, Growth

Geographical Focus
United States, Canada

Industries Focus

  • Healthcare
  • HealthTech
  • Medical Devices
  • Diagnostics

Investment Size:
5,000,000 to 20,000,000 USD

Investor Details Founded: 2019

Sonder Capital is a venture capital firm based in San Carlos, California, specializing in early-stage investments in healthcare technology companies. The firm focuses on sectors such as medical devices, diagnostics, and healthtech, aiming to support innovative teams and technologies that can transform healthcare. Sonder Capital seeks investments that offer transformational innovation enabled by technology, with the potential for significant impact on patient outcomes, access to care, or business models, often supported by the opportunity for a $1 billion or more market capitalization.

The firm's investment strategy involves being actively engaged with portfolio companies, partnering with entrepreneurs as strategic advisors, and providing more than just capital. This hands-on approach allows Sonder Capital to assist entrepreneurs in navigating critical early decisions that can have lasting impacts on long-term success. The team comprises veteran investors, innovators, founder-operators, and company builders with decades of operating experience in the medtech industry.

Sonder Capital was co-founded in 2019 by healthcare luminaries Jay Watkins and Fred Moll, M.D. The firm has a global network of limited partners, including industry leaders, high-net-worth individuals, and leading family offices focused on investing in game-changing healthcare technologies. In April 2024, Sonder Capital appointed Kate Garrett as Managing Partner to lead the next generation of growth, as the firm closed its second early-stage fund, Sonder Futures II. Kate Garrett brings nearly two decades of experience as a successful inventor, founder, and operator across a wide spectrum of companies, from early-stage startups to multinational organizations.

Sonder Capital's portfolio includes companies such as Spirair, BRIUS Technologies, Ziteo, and Neptune Medical. The firm is committed to diversity and recognizes the gap in the diversity of voices heard by the venture community and the number of female and minority-run businesses that receive venture-backed funding. Sonder Capital accepts direct requests from underrepresented individuals in the industry, aiming to change this dynamic.

Sonder Capital's team is known for their individual achievements and collective success in creating, funding, and leading private and public companies that have transformed healthcare for millions of patients globally, including Intuitive Surgical, Shockwave Medical, Procept Biorobotics, Auris Health, and Reflexion Medical, among others.

Requirements
  • Medical device, diagnostic, or healthtech
  • Transformational innovation enabled by technology
  • Significant impact on patient outcomes, access to care, or business model, with potential for a $1 billion+ market cap
Contact

[Official Website Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Spirair
  • BRIUS Technologies
  • Ziteo
  • Neptune Medical
Claim this Investor

Are you an official representative of Sonder Capital?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim